Representative before the EPO

Company dna lds lazewski depo and partners
no operation time available
1 office
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna dennemeyer
operating since 1962
1061.19
Headquarter in Howald and 13 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

We have observed 3 EP applications Sebastian Rafal Walkiewicz has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14729474

METHOD OF CONSTRUCTING PASSIVE FOUNDATIONS THAT REDUCE HEAT LOSS OF A BUILDING, AS WELL AS THE COSTS AND CONSUMPTION OF MATERIALS

IPC classification:
E02D 31/00
Agent:
Sebastian Rafal Walkiewicz, Dennemeyer SA
Status:
The patent has been granted
EP15000566

Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound

IPC classification:
A61K 31/58, A61P 9/14, C07J 63/00
Applicant:
Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Applicant:
Warsaw Medical University (Warszawski Uniwersytet Medyczny)
Agent:
Multiple attorneys, LDS Lazewski Depo & Partners
Status:
EXAMINATION REQUESTED
EP15001035

HORSE CHESTNUT EXTRACT OR ESCINS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

IPC classification:
A61K 36/77, A61P 25/28
Applicant:
Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Applicant:
Warsaw Medical University (Warszawski Uniwersytet Medyczny)
Agent:
Sebastian Rafal Walkiewicz, LDS Lazewski Depo & Partners
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature